BDBM499447 4-((3-(5- (cyclopropylmethoxy)pyrimidin-2- yl)-5-fluorophenoxy)methyl)-N- (methylsulfonyl)benzamide::US11020381, Example 143

SMILES CS(=O)(=O)NC(=O)c1ccc(COc2cc(F)cc(c2)-c2ncc(OCC3CC3)cn2)cc1

InChI Key InChIKey=SHLFOPHIFIPZGD-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 499447   

TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Raqualia Pharma

US Patent
LigandPNGBDBM499447(4-((3-(5- (cyclopropylmethoxy)pyrimidin-2- yl)-5-f...)
Affinity DataIC50: <500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent